Compound information
- Natural Products
- ZC457236
- Molecular Formula
- C13H18N2O4S
- Molecular Weight
- 298.098728056 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(benzenesulfonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C13H18N2O4S/c1-2-19-13(16)14-8-10-15(11-9-14)20(17,18)12-6-4-3-5-7-12/h3-7H,2,8-11H2,1H3
- InChI Key
- QJAUYXLZQGTBOP-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1
- Source
- ZINC000000168060
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 1.478 |
LogS | -2.353 | LogD | 1.698 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.018 | Pgp substrate | 0.022 |
HIA | 0.974 | F20 % | 0.965 |
F30 % | 0.782 | Caco-2 | -4.369 |
MDCK | -4.62 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.816 | PPB | 79.704 |
VD | 0.705 | Fu | 0.728 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.036 | CYP1A2 substrate | 0.476 |
CYP2A6 substrate | 0.768 | CYP2B6 substrate | 0.719 |
CYP2C19 inhibitor | 0.773 | CYP2C19 substrate | 0.82 |
CYP2C8 substrate | 0.588 | CYP2C9 inhibitor | 0.486 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.006 |
CYP2D6 substrate | 0.461 | CYP2E1 substrate | 0.795 |
CYP3A4 inhibitor | 0.005 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.659 | CL | 4.545 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.058 | Hepatotoxicity | 0.789 |
Mutagenicity | 0.12 | Rat Oral Acute Toxicity | 0.31 |
FDAMDD | 0.285 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.836 | Eye Corrosion | 0.003 |
Eye Irritation | 0.169 | Respiratory Toxicity | 0.192 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.688 | IGC50 | 2.915 |
LC50FM | 2.717 | LC50DM | 1.793 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.314 | NR-AR-LBD | 0.393 |
NR-AhR | 0.041 | NR-Aromatase | 0.03 |
NR-ER | 0.28 | NR-ER-LBD | 0.373 |
NR-PPAR-gamma | 0.117 | SR-ARE | 0.188 |
SR-ATAD5 | 0.311 | SR-HSE | 0.087 |
SR-MMP | 0.011 | SR-p53 | 0.023 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.